FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients
H. Andersen (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), M. Mousa (Aarhus, Denmark), N. Mousa (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), T. Smidt-Hansen (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), J. Schmid (Aarhus, Denmark)
Source: International Congress 2022 – Allergy and asthma: biomarkers, phenotypes and real-world evidence
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Andersen (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), M. Mousa (Aarhus, Denmark), N. Mousa (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), T. Smidt-Hansen (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), J. Schmid (Aarhus, Denmark). FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients. 1684
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|